IL-1[beta] binding antibodies for use in treating cancer

Use of an IL-1[beta] binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for thetreatment and/or prevention of cancer with at least partial inflammatory basis. 本公开涉及IL‑1β结合抗体或其功能片段...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	DUGAN MARGARET, OTTEWELL PENELOPE, LIBBY PETER, RIDKER PAUL, LAU YANG YI, LIGUEROS-SAYLAN MONICA, THUREN TOM, MATCHABA PATRICE
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Use of an IL-1[beta] binding antibody or a functional fragment thereof, especially canakinumab or a functional fragment thereof, or gevokizumab or a functional fragment thereof, and biomarkers for thetreatment and/or prevention of cancer with at least partial inflammatory basis. 本公开涉及IL‑1β结合抗体或其功能片段、尤其是卡那吉努单抗或其功能片段或格沃吉珠单抗或其功能片段、以及生物标志物在治疗和/或预防具有至少部分炎症基础的癌症中的用途。